Purchase Order 75N92E23P00196
Award Date 7/25/23
Potential Completion Date 7/24/24
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order valued at twenty thousand two hundred ninety-eight dollars and ninety-nine cents ($20,298.99) to Illumina, Inc. to provide a one-year license for the DRAGEN CS Level 1 throughput of one hundred thousand gigabytes. The license will be delivered under a thirteen point six month period running from May seventh, two thousand twenty-one through...
- This federal contract award, valued at $15,000.00, was issued by the National Human Genome Research Institute (NHGRI) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a DRAGEN CS Level 1 License with a throughput of 100,000GB, with a period of performance from July 25, 2024 to July 24, 2025. The contract is a firm fixed price purchase order and does not have a set-aside designation. Illumina has previously received prime federal...
- This firm-fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for a DRAGEN GCP Level 4 Service License to enable NIDA's Neurodegenerative Diseases Research Section to process high-quality genome data from 10,000 patients with neurodegenerative diseases. The DRAGEN platform performs optimized algorithms for alignment, variant calling, and other advanced genomic analyses....
- This contract was awarded by the National Cancer Institute (NCI), Center for Biomedical Informatics and Information Technology (CBIIT) to Illumina, Inc., a biotechnology company specializing in genetic sequencing and analysis technologies. The $79,432 firm-fixed-price contract is for the purchase of two annual software licenses for Illumina's DRAGEN Server processors with 250,000GB throughput capacity, along with two annual DRAGEN Server Advance Exchange Support Plans. The contract supports...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc. for a DRAGEN Appliance for HIVE, including the license, platform, installation, and support plan. The contract has a potential value of $255,450.00 and a completion date of August 28, 2024. Illumina, a manufacturer of goods, has previously received prime federal contracts and subcontracts from agencies such as the National Institutes of Health, Centers for...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $15,613.88 firm fixed price delivery order to Illumina, Inc. under contract number QTE# 00015178.1. The place of performance will be Illumina's facilities located in San Diego, California. The period of performance is July 31, 2023 for genomic sequencing and analysis services to support the Institute's research efforts aimed at advancing the understanding of the human...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the provision of a DRAGEN Appliance for HIVE. The total potential value of the contract is $210,454.80, with a completion date of September 21, 2024. Illumina has a history of providing sequencing instruments, consumables, and support services to various federal agencies, including the...
- This firm fixed price purchase order was awarded to Illumina, Inc. by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), for the deployment of two Illumina DRAGEN Server v4 systems and associated licenses. The total ceiling value of the contract is $200,500.00, with a period of performance through October 26, 2025. The original solicitation indicates that the NCI requires the DRAGEN processors to support its Whole Genome and Whole Exome Data Processing...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute (HHS-NIH-NHGRI) awarded a $2,075,510.37 delivery order contract to Illumina, Inc. of San Diego, California. The contract is for Illumina Reagents for Library and Sequencing Reagents, with a period of performance starting on September 20, 2022 through September 19, 2023. The pricing structure is firm fixed price. Illumina will provide reagents and consumables used in...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $75,000 firm fixed price delivery order to Illumina, Inc. of San Diego, California on July 21, 2023. The order was placed under an unspecified government-wide acquisition contract vehicle to support the agency's genomic research efforts. Illumina will provide genomics products and services to the National Human Genome Research Institute to advance the institute's mission...